Published in Curr Opin Urol on March 01, 2002
Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients. J Clin Microbiol (2003) 1.71
Acute pyelonephritis in renal allografts: a new role for microRNAs? Transplantation (2014) 0.90
Cyclosporine A impairs nucleotide binding oligomerization domain (Nod1)-mediated innate antibacterial renal defenses in mice and human transplant recipients. PLoS Pathog (2013) 0.83
Vitamin D deficiency is an independent risk factor for urinary tract infections after renal transplants. Medicine (Baltimore) (2015) 0.78
Urinary Tract Infection among Renal Transplant Recipients in Yemen. PLoS One (2015) 0.77
A Nationwide Assessment of the Burden of Urinary Tract Infection among Renal Transplant Recipients. J Transplant (2015) 0.76
Comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients. Adv Biomed Res (2016) 0.75
Stented ureterovesical anastomosis in renal transplantation: does it influence the rate of urinary tract infections? Eur J Med Res (2010) 0.75
Profile of infections in renal transplant recipients from India. J Family Med Prim Care (2017) 0.75
Differential gene expression pattern in biopsies with renal allograft pyelonephritis and allograft rejection. Clin Transplant (2016) 0.75
The Reasons of Renal Transplant Recipients' Admission to the Emergency Department; a Case Series Study. Emerg (Tehran) (2016) 0.75
Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2010) 5.50
The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity (2008) 4.44
Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant (2004) 4.27
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney Int (2012) 2.38
Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol (2002) 2.02
Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant (2002) 1.81
Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol (2011) 1.74
Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study. BMJ (2009) 1.61
Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here? Nephrol Dial Transplant (2004) 1.59
Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol (2008) 1.54
Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. Crit Care Med (2002) 1.53
Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest (2005) 1.52
Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation (2005) 1.51
Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients. Transpl Int (2012) 1.50
Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis (2002) 1.46
Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol (2012) 1.44
Influence of plasma immunoglobulin level on antibody synthesis. Blood (2002) 1.44
Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients. Clin Biochem (2012) 1.44
A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J Immunol (2010) 1.42
The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function. Am J Kidney Dis (2004) 1.42
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study. Wien Klin Wochenschr (2002) 1.39
Serum amyloid A in uremic HDL promotes inflammation. J Am Soc Nephrol (2012) 1.27
Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study. Clin Nephrol (2012) 1.26
Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2011) 1.25
The versatility of HDL: a crucial anti-inflammatory regulator. Eur J Clin Invest (2010) 1.21
Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol (2005) 1.19
PRE-dialysis survey on anaemia management. Nephrol Dial Transplant (2003) 1.16
Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol (2013) 1.14
Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis (2006) 1.12
Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: involvement of impaired integrin activation and immunologic synapse formation. Arthritis Rheum (2005) 1.12
Pure red cell aplasia induced by erythropoiesis-stimulating agents. Clin J Am Soc Nephrol (2008) 1.11
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. Kidney Int (2003) 1.06
Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood (2011) 1.06
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant (2002) 1.05
Immune dysfunction in uremia—an update. Toxins (Basel) (2012) 1.03
Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure. Eur J Clin Invest (2011) 1.02
Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol (2004) 1.02
Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol (2002) 1.02
HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease. Clin Chim Acta (2011) 1.01
Glucose metabolism after renal transplantation. Diabetes Care (2013) 0.99
Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells. J Leukoc Biol (2002) 0.99
Impairment of transendothelial leukocyte migration by iron complexes. J Am Soc Nephrol (2003) 0.98
Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients. Nephrol Dial Transplant (2002) 0.98
Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant (2013) 0.97
Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant (2002) 0.97
Sodium setpoint and sodium gradient: influence on plasma sodium change and weight gain. Am J Nephrol (2010) 0.97
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity. Transpl Int (2010) 0.96
Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation (2007) 0.93
Prevention of CD40-triggered dendritic cell maturation and induction of T-cell hyporeactivity by targeting of Janus kinase 3. Am J Transplant (2003) 0.93
Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy. Transpl Int (2004) 0.92
Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia. Nephrol Dial Transplant (2007) 0.92
Donor heme oxygenase-1 genotype is associated with renal allograft function. Transplantation (2004) 0.92
Hepcidin: a molecular link between inflammation and anaemia. Nephrol Dial Transplant (2004) 0.91
Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America. Arzneimittelforschung (2011) 0.90
Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort. Transplantation (2004) 0.89
Ferrous sulfate does not affect mycophenolic acid pharmacokinetics in kidney transplant patients. Am J Kidney Dis (2004) 0.89
Iron overload and cardiovascular complications in dialysis patients. Nephrol Dial Transplant (2002) 0.88
The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function. Arthritis Res Ther (2005) 0.88
Angiogenic factors in plasma of brain tumour patients. Anticancer Res (2009) 0.87
Resistin inhibits essential functions of polymorphonuclear leukocytes. J Immunol (2008) 0.87
p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycin. J Immunol (2013) 0.87
Antithymocyte globulin impairs T-cell/antigen-presenting cell interaction: disruption of immunological synapse and conjugate formation. Transplantation (2007) 0.87
A critical appraisal for definition of hyperfiltration. Am J Kidney Dis (2004) 0.87
Immunoadsorption and plasma exchange in pregnancy. Kidney Blood Press Res (2002) 0.87
Vitamin C in chronic kidney disease and hemodialysis patients. Kidney Blood Press Res (2003) 0.86
Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease. Drugs (2004) 0.86
ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations. Nephrol Dial Transplant (2008) 0.85
Increased total cytokeratin-18 serum and urine levels in chronic kidney disease. Clin Chim Acta (2010) 0.85
Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation (2008) 0.85
Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients. J Am Soc Nephrol (2002) 0.85
Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patients. J Am Soc Nephrol (2005) 0.84
Potential risk for infection and atherosclerosis due to iron therapy. J Ren Nutr (2005) 0.84
Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patients. Nephrol Dial Transplant (2011) 0.84
Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin. Semin Dial (2009) 0.84
Prognostic associations between lipid markers and outcomes in kidney transplant recipients. Am J Kidney Dis (2006) 0.84
Drug therapy for hypertension in hemodialysis patients. Semin Dial (2004) 0.84
C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant (2004) 0.83
Anaemia as a risk factor for the progression of chronic kidney disease. Curr Opin Nephrol Hypertens (2003) 0.83
Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. Kidney Int (2005) 0.83
Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial. Trials (2012) 0.83
Free immunoglobulin light chains as a risk factor in renal and extrarenal complications. Semin Dial (2009) 0.83
Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients. Transpl Immunol (2006) 0.82
Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. Nephrol Dial Transplant (2004) 0.82
The role of EUTox in uremic toxin research. Semin Dial (2009) 0.82
Natriuretic peptides in chronic kidney disease and during renal replacement therapy: an update. J Investig Med (2009) 0.82
Antioxidants: a possible role in kidney protection. Kidney Blood Press Res (2003) 0.82
Gender and living donor kidney transplantation. Wien Med Wochenschr (2011) 0.82
Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. Kidney Int (2004) 0.81
Angiogenin: a novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation. Kidney Blood Press Res (2003) 0.81
Pre-transplant predictors of cerebrovascular events after kidney transplantation. Nephrol Dial Transplant (2007) 0.81
Effects of Tamm-Horsfall protein on polymorphonuclear leukocyte function. Nephrol Dial Transplant (2004) 0.81
Hyporesponsiveness in alloreactive T-cells by NF-kappaB inhibitor-treated dendritic cells: resistance to calcineurin inhibition. Am J Transplant (2004) 0.81
Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol (2004) 0.81
Glucose control is associated with patient survival in diabetic patients after renal transplantation. Transplantation (2010) 0.81
Endothelial progenitor cells in kidney transplant recipients. Transplantation (2006) 0.81
Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status. BMC Nephrol (2013) 0.81
The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients. Nephrol Dial Transplant (2008) 0.81
History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. Am J Kidney Dis (2005) 0.81
Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney Int (2005) 0.80